Editorial: Challenges in developing new multiple sclerosis therapies Dahkki Michael K. Racke

Viečča ollesdeavstta

Natalizumab: increased vigilance is required in treating patients with multiple sclerosis Dahkki Michael K. Racke, Olaf Stüve

Viečča ollesdeavstta

PPARs in Neuroinflammation Dahkki Paul D. Drew, Michael K. Racke

Viečča ollesdeavstta

Pain in Multiple Sclerosis: Understanding Pathophysiology, Diagnosis, and Management Through Clinical Vignettes Dahkki Michael K. Racke, Elliot M. Frohman, Teresa Frohman

Viečča ollesdeavstta

Regulation of Immune Responses and Autoimmune Encephalomyelitis by PPARs Dahkki Yuhong Yang, Amy E. Lovett-Racke, Michael K. Racke

Viečča ollesdeavstta

PPAR Alpha Regulation of the Immune Response and Autoimmune Encephalomyelitis Dahkki Michael K. Racke, Paul D. Drew, Amy Lovett-Racke, Yuhong Yang, Anne R. Gocke

Viečča ollesdeavstta

Reactivation of human herpesvirus-6 in natalizumab treated multiple sclerosis patients. Dahkki Karen Yao, Susan Gagnon, Nahid Akhyani, Elizabeth Williams, Julie Fotheringham, Elliot Frohman, Olaf Stuve, Nancy Monson, Michael K Racke, Steven Jacobson

Viečča ollesdeavstta

PEG minocycline-liposomes ameliorate CNS autoimmune disease. Dahkki Wei Hu, Josbert Metselaar, Li-Hong Ben, Petra D Cravens, Mahendra P Singh, Elliot M Frohman, Todd N Eagar, Michael K Racke, Bernd C Kieseier, Olaf Stüve

Viečča ollesdeavstta

A STAT3 inhibitor ameliorates CNS autoimmunity by restoring Teff:Treg balance Dahkki Saba I. Aqel, Xiaozhi Yang, Emma E. Kraus, Jinhua Song, Marissa F. Farinas, Erin Y. Zhao, Wei Pei, Amy E. Lovett-Racke, Michael K. Racke, Chenglong Li, Yuhong Yang

Viečča ollesdeavstta

Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis. Dahkki Nancy L Monson, Petra Cravens, Rehana Hussain, Christopher T Harp, Matthew Cummings, Maria de Pilar Martin, Li-Hong Ben, Julie Do, Jeri-Anne Lyons, Amy Lovette-Racke, Anne H Cross, Michael K Racke, Olaf Stüve, Mark Shlomchik, Todd N Eagar

Viečča ollesdeavstta

Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer’s disease assessment Dahkki Darren M. Weber, Steven W. Taylor, Robert J. Lagier, Jueun C. Kim, Scott M. Goldman, Nigel J. Clarke, David E. Vaillancourt, Ranjan Duara, Ranjan Duara, Karen N. McFarland, Wei-en Wang, Todd E. Golde, Todd E. Golde, Michael K. Racke

Viečča ollesdeavstta

K27-linked RORγt ubiquitination by Nedd4 potentiates Th17-mediated autoimmunity Dahkki Qiuming Zeng, Hui Guo, Na Tang, Pranav S. Renavikar, Nitin J. Karandikar, Amy E. Lovett-Racke, Michael K. Racke, Chengkai Yan, Rong Tang, Sushmita Sinha, Krishnendu Ghosh, Jeremy P. Ryal, Song Ouyang, Min Chen, Foued Amari, Coppola Vincenzo, R. Marshall Pope, Yalan Li, Huan Yang, Wallace Y. Langdon, Jian Zhang

Viečča ollesdeavstta

A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple scler... Dahkki Elliot M. Frohman, Gary Cutter, Gina Remington, Hongjiang Gao, Howard Rossman, Bianca Weinstock-Guttman, Jacqueline E. Durfee, Amy Conger, Ellen Carl, Katherine Treadaway, Eric Lindzen, Amber Salter, Teresa C. Frohman, Anjali Shah, Angela Bates, Jennifer L. Cox, Michael G. Dwyer, Olaf Stuve, Benjamin M. Greenberg, Michael K. Racke, Robert Zivadinov

Viečča ollesdeavstta

Prior cycles of anti-CD20 antibodies affect antibody responses after repeated SARS-CoV-2 mRNA vaccination Dahkki Hiromitsu Asashima, Dongjoo Kim, Kaicheng Wang, Nikhil Lele, Nicholas C. Buitrago-Pocasangre, Rachel Lutz, Isabella Cruz, Khadir Raddassi, William E. Ruff, Michael K. Racke, JoDell E. Wilson, Tara S. Givens, Alba Grifoni, Daniela Weiskopf, Alessandro Sette, Steven H. Kleinstein, Ruth R. Montgomery, Albert C. Shaw, Fangyong Li, Rong Fan, David A. Hafler, Mary M. Tomayko, Erin E. Longbrake

Viečča ollesdeavstta